Literature DB >> 23078161

One-hour post-load plasma glucose and IGF-1 in hypertensive patients.

Francesco Perticone1, Angela Sciacqua, Eliezer J Tassone, Sofia Miceli, Raffaele Maio, Desirée Addesi, Tania Falbo, Franco Arturi, Giorgio Sesti.   

Abstract

BACKGROUND: In normoglucose-tolerant subjects (NGT), 1-h post-load plasma glucose value ≥155 mg/dL, during an oral glucose tolerance test (OGTT), is associated with an increased risk of type-2 diabetes (T2D) and subclinical organ damage. Insulin-like growth factor-1 (IGF-1) is involved in the pathogenesis of insulin resistance (IR) and T2D. Moreover, hypertensives have different degrees of IR and different levels of IGF-1. Actually, there are no data supporting the association between post-load glucose and IGF-1; thus, the aim of the study was to investigate this relationship.
MATERIALS AND METHODS: We enrolled 1126 never-treated hypertensive subjects who underwent an OGTT and clinical characterization. Insulin sensitivity was assessed by the Matsuda index. IGF-1 was measured by a sensitive immunoradiometric assay.
RESULTS: Among participants, 764 had NGT, 263 had impaired glucose tolerance (IGT) and 99 had T2D. According to the 1-h post-load plasma glucose cut-off point of 155 mg/dL, we divided NGT subjects into NGT < 155 mg/dL and NGT ≥ 155 mg/dL. NGT ≥ 155 in comparison with NGT < 155 had significantly reduced insulin sensitivity and IGF-1 levels. At multiple regression analysis, IGF-1 was the major determinant of 1-h post-load glucose in NGT ≥ 155 subjects, IGT and diabetics, accounting for 20·9%, 17·7% and 15·5% of its variation in the respective models.
CONCLUSIONS: In hypertensive NGT ≥ 155 subjects, IGF-1 results strongly associated with 1-h post-load glucose, similarly to that observed in IGT and diabetics. This finding has clinical relevance because both low IGF-1 levels and 1-h post-load glucose in NGT subjects are associated with subclinical organ damage, an independent predictor of cardiovascular events.
© 2012 The Authors. European Journal of Clinical Investigation © 2012 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23078161     DOI: 10.1111/eci.12005

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

1.  Serum Insulin-Like Growth Factor 1 and the Risk of Ischemic Stroke: The Framingham Study.

Authors:  Hamidreza Saber; Jayandra J Himali; Alexa S Beiser; Ashkan Shoamanesh; Aleksandra Pikula; Ronenn Roubenoff; Jose R Romero; Carlos S Kase; Ramachandran S Vasan; Sudha Seshadri
Journal:  Stroke       Date:  2017-06-08       Impact factor: 7.914

2.  Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease.

Authors:  Giorgio Sesti; Marta Letizia Hribal; Teresa Vanessa Fiorentino; Angela Sciacqua; Francesco Perticone
Journal:  BMJ Open Diabetes Res Care       Date:  2014-08-08

3.  Relationship between serum insulin-like growth factor 1 levels and ischaemic stroke: a systematic review and meta-analysis.

Authors:  Yangni Li; Weinan Yang; Jinhui Li; Yishu Zhang; Lincheng Zhang; Simiao Chen; Lan He; Yuyan Zhang
Journal:  BMJ Open       Date:  2022-06-15       Impact factor: 3.006

4.  Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels.

Authors:  Maria Adelaide Marini; Simona Frontoni; Elena Succurro; Franco Arturi; Teresa Vanessa Fiorentino; Angela Sciacqua; Marta Letizia Hribal; Francesco Perticone; Giorgio Sesti
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.